| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A16AX01 |
Structure
| InChI Key | AGBQKNBQESQNJD-SSDOTTSWSA-N |
|---|---|
| Smile | |
| InChI |
|
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Diabetic Neuropathies; Polyneuropathies | Phase 3 | ClinicalTrials |
| Cognition Disorders; Dementia | Phase 2 | ClinicalTrials |
| Peripheral Nervous System Diseases | Phase 1/Phase 2 | ClinicalTrials |
| Coronary Artery Disease; Coronary Disease; Myocardial Ischemia | Phase 4 | ClinicalTrials |
| Schizophrenia | Phase 2/Phase 3 | ClinicalTrials |
| Heart Failure; Ischemia | Phase 4 | ClinicalTrials |
| Diabetic Neuropathies; Polyneuropathies | Phase 3 | ClinicalTrials |
| Fatty Liver; Hepatitis; Non-alcoholic Fatty Liver Disease | Phase 4 | ClinicalTrials |
| Multiple Sclerosis; Sclerosis | Phase 1/Phase 2 | ClinicalTrials |
| Neoplasms; Neurotoxicity Syndromes; Peripheral Nervous System Diseases | Phase 3 | ClinicalTrials |
| Autonomic Nervous System Diseases; Cardiomyopathies; Nervous System Diseases; Takotsubo Cardiomyopathy | Phase 4 | ClinicalTrials |
CONTENTS